HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 561/1/245    most recent jphysiol.2004.073635v1 Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Felies, M. Articles by Nave, H. Search for Related Content PubMed PubMed Citation Articles by Felies, M. Articles by Nave, H.

¹ Functional and Applied Anatomy, Hannover Medical School, Hannover, Germany

The on-going high mortality from sepsis motivates continuous research for novel therapeutic strategies. Neuropeptide Y (NPY), a sympathetic neurotransmitter, has been shown to increase survival in experimental septic shock in rats. This protective effect might be due to immunological, cardiovascular or thermoregulatory effects. The aim of this study was to examine the in vivo effect of peripherally administered NPY on body temperature, blood pressure and heart rate in endotoxaemic animals. In order to obtain clinically relevant data, various physiological parameters were monitored in parallel via radio-telemetry in chronically intravenously cannulated, freely behaving rats. Rats received a sublethal bolus of lipopolysaccharide (LPS, 100 µg kg^–1 I.V.) and the three parameters were continuously recorded for 72 h. Endotoxaemic rats showed a long-lasting hypotension, an initial hypothermia (–0.5°C), followed by a prolonged febrile phase (+1.6°C 6 h after endotoxin challenge) associated with a decrease of the circadian rhythm amplitude of temperature. Pretreatment with NPY (160 pmol kg^–1 I.V. over 75 min) prevented hypotension and significantly stabilized body temperature immediately following the application. The febrile phase was effectively reduced for at least 72 h. These telemetrically obtained findings clearly demonstrate that pretreatment with NPY positively influences two life-threatening symptoms in endotoxaemia and might be a future option for a successful clinical treatment regimen.

(Received 11 August 2004; accepted after revision 17 September 2004; first published online 23 September 2004)
Corresponding author H. Nave: Department of Functional and Applied Anatomy, OE4120, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. Email: nave.heike{at}mh-hannover.de

This article has been cited by other articles:

				T. J. Sajdyk, P. L. Johnson, R. J. Leitermann, S. D. Fitz, A. Dietrich, M. Morin, D. R. Gehlert, J. H. Urban, and A. Shekhar Neuropeptide Y in the Amygdala Induces Long-Term Resilience to Stress-Induced Reductions in Social Responses But Not Hypothalamic-Adrenal-Pituitary Axis Activity or Hyperthermia J. Neurosci., January 23, 2008; 28(4): 893 - 903. [Abstract] [Full Text] [PDF]

				E. S. Akarsu and S. Mamuk Escherichia coli lipopolysaccharides produce serotype-specific hypothermic response in biotelemetered rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1846 - R1850. [Abstract] [Full Text] [PDF]